This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Boehringer Ingelheim Pharma Kg. Active years: 2003.
Company Filing History:
Years Active: 2003
Title: The Innovative Contributions of Alessandro Brambilla
Introduction
Alessandro Brambilla is a notable inventor based in Milan, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that interact with serotonin and dopamine receptors. With a total of 2 patents, his work has garnered attention in the scientific community.
Latest Patents
Brambilla's latest patents include innovative compounds such as benzimidazolone derivatives that display affinity at the serotonin and dopamine receptors. These compounds are crucial for understanding and potentially treating various neurological conditions. His work on N,N'-disubstituted benzimidazolone derivatives further emphasizes his focus on developing effective pharmaceutical agents.
Career Highlights
Throughout his career, Alessandro Brambilla has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Boehringer Ingelheim Pharma KG and Sprout Pharmaceuticals, Inc. His experience in these organizations has allowed him to contribute to significant advancements in drug development.
Collaborations
Brambilla has collaborated with esteemed colleagues such as Enzo Cereda and Luciano Maiocchi. These partnerships have facilitated the exchange of ideas and expertise, enhancing the quality of his research and innovations.
Conclusion
Alessandro Brambilla's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical science.